Novel Risk Factors for Venous Thromboembolism

Squizzato, Alessandro; Brivio, Lorenza; Appio, Lorena; Dentali, Francesco

doi:10.1016/j.hoc.2010.05.007

Cited by 5 publications

(3 citation statements)

References 52 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Identifikovani su brojni faktori rizika koji prolazno ili stalno povećavaju mogućnost razvoja VTE, provociranjem hiperkoagulabilnosti, staze venskog protoka ili oštećenja venskog zida (tabela 1). Najvažniji i najčešće udruženi sa nastankon VTE su hiruško lečenje, imobilizacija i maligna oboljenja [1,14]. Ipak, kod blizu polovine slučajeva VTE nijedan od provocirajućih faktora se ne može identifikovati.…”

Section: Venski Tromboembolizam (Vte)unclassified

Emergency conditions in vein disease

Atanasijevic¹,

Radak²,

Đukić³

et al. 2019

NČ urgent medic Halo 194

View full text Add to dashboard Cite

Emergency conditions in vein disease are deep vein thrombosis or phlebothrombosis and superficial vein thrombosis or thrombophlebitis. They occur globaly in general population and are a significant cause of morbidity and mortality. Since deep vein thrombosis and pulmonary embolism very often come together, they are both reffered to as venous thromboembolism. Early recognition of deep or superficial vein thrombosis is extremely important and therapy with anticoagulants should immediately be innitiated in order to prevent potentially life-threatening thromboembolic complications. Thrombophlebitis is usually diagnosed through physical examination, but patients should be refered to dopler ultrasound of lower extremity veins to rule out the existence of deep vein thrombosis. Venous thromboembolism is initially diagnosed using a clinical scoring system to point out patients with high risk, and also the level of D-dimer in the blood. High risk patients with high probability of venous thromboembolism and high levels of D-dimer are then referred to further diagnostic procedures. Direct oral anticoagulants are the first line of treatment in venous thromboembolism therapy, since they carry a lower risk of haemorrhagic complications that vitamin K antagonists, as well as easier implementation without the need for monitoring. Anticoagulant therapy is used for at least three months in order to prevent early recidives, while patients with high risk of suffering from venous thromboembolism again should be taking prolonged anticoagulant therapy. Anticoagulant therapy, most commonly low-molecular heparin, together with the symptomatic therapy of non-steroid antiinflammatory drugs, is the base for treating thrombophlebitis.

show abstract

Section: Venski Tromboembolizam (Vte)unclassified

Emergency conditions in vein disease

Atanasijevic¹,

Radak²,

Đukić³

et al. 2019

NČ urgent medic Halo 194

View full text Add to dashboard Cite

show abstract

“…Introduction Atherosclerosis, diabetes mellitus, vasculitis, grafts and prosthetic valves, conditions leading to stasis, hyperviscosity, myeloproliferative diseases, and thrombotic abnormalities such as thrombocytosis, coagulation disorders, and disorders of the fibrinolytic system are predisposing factors for thromboembolic diseases [1,2]. Homocysteine (hcy) is not found in the diet, but it is an intermediate metabolite of methionine metabolism [3].…”

mentioning

confidence: 99%

The Levels of Serum B12, Folic Acid and Homocysteine in the Thromboembolic Diseases

Karabulut¹

2017

Ann Clin Anal Med

View full text Add to dashboard Cite

“…However, even in the presence of such predisposing conditions, thrombus formation in the individual patient may be favored by the interplay with additional underlying genetic or acquired minor risk factors, whose role may become necessary to produce clinically apparent thrombosis (1). Over the last years, a number of new risk factors were shown to be significantly associated with VTE, although the magnitude of the association was weaker than that of the previously cited conditions (4).…”

mentioning

confidence: 99%